These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10560523)

  • 1. Inhibition of DNA synthesis in isolated human endometrial cells by a levonorgestrel-releasing intrauterine device.
    Luo H; Zhu P; Xu R; Cheng J; Zhao X; Wang JD
    Anal Quant Cytol Histol; 1999 Oct; 21(5):409-12. PubMed ID: 10560523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of levonorgestrel-releasing intrauterine device (20 micrograms/day) (LNG-IUD-20) on the morphological structure of human endometrium: a study of the endometrial factor VIII activity in the women before and after insertion of LNG-IUD-20 by the digital image analysis.
    Zhu P; Liu X; Luo H; Gu Z; Wang J; Xu L; Cheng J; Xu R; Lian S; Cui Y
    Contraception; 1995 Jul; 52(1):63-8. PubMed ID: 8521717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ.
    Gu Z; Zhu P; Luo H; Zhu X; Zhang G; Wu S
    Contraception; 1995 Jul; 52(1):57-61. PubMed ID: 8521716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intrauterine devices (stainless steel ring, copper-T220 and levonorgestrel) on the DNA content in isolated human endometrial cells.
    Zhu PD; Luo HZ; Cheng J; Xu RH; Liu YF; Zheng WM; Song GY; Chen JH; Zhou ZH; Wu YM
    Contraception; 1989 Nov; 40(5):591-604. PubMed ID: 2515028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs.
    Vieira CS; Pack A; Roberts K; Davis AR
    Contraception; 2019 Apr; 99(4):251-255. PubMed ID: 30529085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium.
    Salmi A; Pakarinen P; Peltola AM; Rutanen EM
    Mol Hum Reprod; 1998 Dec; 4(12):1110-5. PubMed ID: 9872360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial effects of intrauterine levonorgestrel.
    Guttinger A; Critchley HO
    Contraception; 2007 Jun; 75(6 Suppl):S93-8. PubMed ID: 17531624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use.
    Zhu P; Liu X; Luo H; Gu Z; Cheng J; Xu R; Lian S; Wu S; Wang J
    Hum Reprod; 1999 Apr; 14(4):970-5. PubMed ID: 10221229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of combined endometrial resection or ablation and levonorgestrel intrauterine device on postoperative bleeding pattern.
    Heinemeier IIK; Messerschmidt L; Kragsig Thomsen T; Bertelsen PK; Rudnicki M
    Arch Gynecol Obstet; 2023 Feb; 307(2):493-499. PubMed ID: 36129518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levonorgestrel-releasing intrauterine device potentiates stress reactivity.
    Aleknaviciute J; Tulen JHM; De Rijke YB; Bouwkamp CG; van der Kroeg M; Timmermans M; Wester VL; Bergink V; Hoogendijk WJG; Tiemeier H; van Rossum EFC; Kooiman CG; Kushner SA
    Psychoneuroendocrinology; 2017 Jun; 80():39-45. PubMed ID: 28315609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
    Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.